Patents by Inventor Mark Rochman

Mark Rochman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating allergic inflammation through inhibition of NTRK1
    Patent number: 9517238
    Abstract: The invention provides methods of treating allergic inflammatory conditions using an anti-neurotrophin tyrosine kinase receptor 1 (NTRK1)-based therapeutic agent, and related compositions and methods.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: December 13, 2016
    Assignee: CHILDREN'S HOSPITAL MEDICAL CENTER
    Inventors: Mark Rochman, Marc E. Rothenberg
  • COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATION THROUGH INHIBITION OF NTRK1
    Publication number: 20160129012
    Abstract: The invention provides methods of treating allergic inflammatory conditions using an anti-neurotrophin tyrosine kinase receptor 1 (NTRK1)-based therapeutic agent, and related compositions and methods.
    Type: Application
    Filed: November 6, 2015
    Publication date: May 12, 2016
    Inventors: Mark Rochman, Marc E. Rothenberg